Stock Events

Stock Events

Organovo 

$2.04
79
+$0.03+1.49% Wednesday 20:00

Statistics

Day High
2.16
Day Low
1.94
52W High
21.96
52W Low
1.56
Volume
184,048
Avg. Volume
760,714
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21MayExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-2.52
-2.36
-2.2
-2.04
Expected EPS
-2.04
Actual EPS
N/A

Financials

-13,459.63%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
109,000Revenue
-14.67MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONVO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in biopharmaceuticals and has investments in regenerative medicine and tissue engineering, competing in similar spaces as Organovo.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that engages in research and development in biotech and regenerative medicine, areas where Organovo also operates.
Merck
MRK
Mkt Cap214.76B
Merck operates in the pharmaceutical and biotech sectors, focusing on innovative treatments that could overlap with Organovo's 3D bioprinting technologies.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers products and services in the life sciences field, including technologies that could compete with Organovo's bioprinting solutions.
Danaher
DHR
Mkt Cap152.13B
Danaher is a global science and technology innovator with businesses in life sciences and diagnostics, potentially competing with Organovo's offerings.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals focuses on regenerative medicine and biotechnology, directly competing with Organovo's research and development in 3D bioprinting.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomics solutions, which could be used in conjunction with or in competition to Organovo's bioprinting technologies for personalized medicine.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers products and services in the life science research and clinical diagnostics markets, potentially competing with Organovo's technologies.
Stryker
SYK
Mkt Cap136.19B
Stryker is a medical technologies firm with products that could compete with Organovo's in areas such as surgical applications and regenerative medicine.

About

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
Show more...
CEO
Mr. Keith E. Murphy
Employees
14
Country
US
ISIN
US68620A1043

Listings

XNAS
US
VIVS
F
DE
4OR.F
LSE
GB
0R02.LSE
BOATS
BOATS
VIVS.BOATS

0 Comments

Share your thoughts

FAQ

What is Organovo stock price today?▼
The current price of ONVO is $2.04 USD — it has increased by +1.49% in the past 24 hours. Watch Organovo stock price performance more closely on the chart.
What is Organovo stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Organovo stocks are traded under the ticker ONVO.
Is Organovo stock price growing?▼
ONVO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Organovo has showed a -3.77% decrease.
What is Organovo revenue for the last year?▼
Organovo revenue for the last year amounts to 109,000 USD.
What is Organovo net income for the last year?▼
ONVO net income for the last year is -14.67M USD.
How many employees does Organovo have?▼
As of April 05, 2026, the company has 14 employees.
In which sector is Organovo located?▼
Organovo operates in the Health Care sector.
When did Organovo complete a stock split?▼
The last stock split for Organovo was on March 21, 2025 with a ratio of 1:12.
Where is Organovo headquartered?▼
Organovo is headquartered in San Diego, US.